NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 315
Auteur Titel [ Jaar(Asc)]
2017
Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens A, Loonen AJM.  2017.  The role of the habenula in the transition from reward to misery in substance use and mood disorders.. Neurosci Biobehav Rev.
Wits E, Croes E, Dijkstra BAG, van Nattum M.  2017.  Standaarden bieden houvast aan alle zorgverleners. Medisch Contact.
Swerts C, Vandevelde S, VanDerNagel JEl, Vanderplasschen W, Claes C, De Maeyer J.  2017.  Substance use among individuals with intellectual disabilities living independently in Flanders.. Res Dev Disabil. 63:107-117.
VanDerNagel JEl, Kiewik M, van Dijk M, Didden R, Korzilius HPLM, van der Palen J, Buitelaar JK, Uges DRA, Koster RA, DeJong CA.  2017.  Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.. Res Dev Disabil. 63:151-159.
van Noorden MS, Mol T, Wisselink J, Kuijpers W, Dijkstra BAG.  2017.  Treatment consumption and treatment re-enrollment in GHB-dependent patients in The Netherlands. Drug Alcohol Depend. 176:96-101.
Ter Huurne ED, Postel MG, de Haan HA, van der Palen J, de Jong CAJ.  2017.  Treatment dropout in web-based cognitive behavioral therapy for patients with eating disorders.. Psychiatry Research. 247
Ter Huurne ED, Postel MG, de Haan HA, van der Palen J, de Jong CAJ.  2017.  Treatment dropout in web-based cognitive behavioral therapy for patients with eating disorders.. Psychiatry Research. 247
Wieferink C.E.M., de Haan H.A., Dijkstra B.A.G., Fledderus M., Kok T..  2017.  Treatment of substance use disorders: Effects on patients with higher or lower levels of PTSD symptoms.. Addictive Behaviors. 74
Kok T., de Haan H.A., Sensky T., van der Meer M., De Jong C.A.J..  2017.  Using the Pictorial Representation of Illness and Self Measure (PRISM) to Quantify and Compare Suffering From Trauma and Addiction.. Journal of Dual Diagnosis . 13(2)
Kok T..  2017.  Using the Pictorial Representation of Illness and Self Measure (PRISM) toe Quantify and Compare Suffering From Trauma and Addiction. Journal of Dual Diagnosis. 13(2)
Dijkstra BAG, Lammers S, Andrea H, Egger J.  2017.  Wetenschappelijk onderzoek in de praktijk. Een relevante uitdaging. Onderzoeksverslagen van de opleiding Klinisch Psycholoog V&O 2012 en 2013.
2016
Otte RA, Verbrugge CAG, Dijkstra BAG.  2016.  Aanbevelingen voor ketenzorg bij GHB gerelateerde problemen. NISPA GHB Onderzoek.
Ayu AParawita, Iskandar S, Siste K, DeJong CA, Schellekens A.  2016.  Addiction training for health professionals as an antidote to the addiction health burden in Indonesia.. Addiction. 111(8):1498-9.
Markus W.  2016.  Are addiction-related memories malleable by working memory competition? Transient effects on memory vividness and nicotine craving in a randomized lab experiment. Behavioral Therapy and Experimental Psychiatry. (52):83-91.
Blanco-Hinojo L, Pujol J, Harrison BJ, Macià D, Batalla A, Nogué S, Torrens M, Farré M, Deus J, Martin-Santos R.  2016.  Attenuated frontal and sensory inputs to the basal ganglia in cannabis users.. Addict Biol.
Beurmanjer H., Verbrugge CAG, Schrijen S, Schellekens A, DeJong CA, Dijkstra BAG.  2016.  Behandeling van GHB afhankelijkheid na detoxificatie. Eindrapportage NISPA GHB monitor 2.0.
Merkx M.JM, De Fuentes-Merillas L, Koeter M.J.W., Schippers G.M..  2016.  Bruikbaarheid en toepasbaarheid van Contingency Management gecombineerd met een cognitief gedragstherapeutische behandeling voor middelengebruik binnen de reguliere ambulante forensische zorg.
Lorenzetti V, Batalla A, Cousijn J.  2016.  Cannabis use disorders and neuroanatomical alterations: Where is the evidence? Current Addiction Reports. 3(2):189-198.
Jacobs A, Stalpers-Konijnenburg SC, DeJong CA, Marijnissen RM.  2016.  Chronic Stimulant Use: An Upcoming Cause of Neurocognitive Disorder in Later Life? Clinical Medical Reviews and Case Reports. 3(1)
van Duijvenbode N, Didden R, VanDerNagel JEl, Korzilius HPlm, Engels RCme.  2016.  Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability.. J Intellect Disabil. :1744629516664840.
Groenman AP, Greven CU, van Donkelaar MMJ, Schellekens A, van Hulzen KJE, Rommelse N, Hartman CA, Hoekstra PJ, Luman M, Franke B et al..  2016.  Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder.. Addict Biol. 21(4):915-23.
Markus W.  2016.  EMDR interventions in addiction.. Journal of EMDR Practice and Research. 11(1)
Brunt TM, van Noorden M, Kamal RM, Dijkstra BAG, DeJong CA.  2016.  Epidemiology of Gamma-hydroxybutyrate (GHB) use and misuse and characteristics of GHB-dependent inpatients. The Neuropathology Of Drug Addictions And Substance Misuse.
van Noorden M, Kamal RM, Dijkstra BAG, Brunt TM, DeJong CA.  2016.  Gamma-Hydroxybutyrate Abuse and Dependence . Neuropathology of Drug Addictions and Substance Misuse . Volume 2: Stimulants, Club and Dissociative Drugs, Hallucinogens, Steroids, Inhalants, and International Aspects
Mackey S, Kan K-J, Chaarani B, Alia-Klein N, Batalla A, Brooks S, Cousijn J, Dagher A, de Ruiter M, Desrivieres S et al..  2016.  Genetic imaging consortium for addiction medicine: From neuroimaging to genes.. Prog Brain Res. 224:203-23.

Pagina's